Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Khuloud Saleh"'
Autor:
Rajaie Namas, Mohamed Elarabi, Fouad Fayad, Aqeel A Muhanna Ghanem, Adeeba Al-Herz, Waleed Hafiz, Abhay Joshi, Mira Merashli, Jad Okais, Imad Uthman, Khuloud Saleh Essa, Mohammed A Omair
Publikováno v:
Open Access Rheumatology: Research and Reviews. 15:93-102
Rajaie Namas,1 Mohamed Elarabi,1 Fouad Fayad,2 Aqeel A Muhanna Ghanem,3 Adeeba Al-Herz,4 Waleed Hafiz,5 Abhay Joshi,6 Mira Merashli,7 Jad Okais,2 Imad Uthman,7 Khuloud Saleh Essa,8 Mohammed A Omair9 1Department of Internal Medicine, Division of Rheum
Autor:
Hebah, Al-Hajeri, Fatemah, Baroun, Fatemah, Abutiban, Muna, Al-Mutairi, Yasser, Ali, Adel, Alawadhi, Anwar, Albasri, Ali, Aldei, Ahmad, AlEnizi, Naser, Alhadhood, Adeeba, Al-Herz, Amjad, Alkadi, Waleed, Alkanderi, Ammar, Almathkoori, Nora, Almutairi, Saud, Alsayegh, Ali, Alturki, Husain, Bahbahani, Ahmad, Dehrab, Aqeel, Ghanem, Eman, Haji Hasan, Sawsan, Hayat, Khuloud, Saleh, Hoda, Tarakmeh
Publikováno v:
Postgraduate Medicine. 134:160-179
The emergency state caused by COVID-19 saw the use of immunomodulators despite the absence of robust research. To date, the results of relatively few randomized controlled trials have been published, and methodological approaches are riddled with bia
Autor:
Namas, Rajaie, Elarabi, Mohamed, Fayad, Fouad, Ghanem, Aqeel A Muhanna, Al-Herz, Adeeba, Hafiz, Waleed, Joshi, Abhay, Merashli, Mira, Okais, Jad, Uthman, Imad, Essa, Khuloud Saleh, Omair, Mohammed A
Publikováno v:
Open Access Rheumatology: Research & Reviews; May2023, Vol. 15, p93-102, 10p
Autor:
Husain Bahbahani, Ahmed Al-Saber, Khaled Mokaddem, F. Abutiban, Youssef Bartella, Mohammed Hussain, Yaser Ali, Ahmad Khadrawy, Hebah Alhajeri, Aqeel Ghanem, Sally Hamed, Ghada Mazloum, Adeeba Al-Herz, Hoda Tarakmeh, E. Nahar, Ali Aldei, A. Zaman, Khuloud Saleh, Eman Hasan, Ahmad Alenizi, N. Alhadhood, Sawsan Hayat, Waleed Al-Kandari, Adel Al-Awadhi, Ammad Fazal, Ramia Alsouk
Publikováno v:
Clinical Rheumatology
Objective Biologics are indicated in rheumatoid arthritis (RA) in case of persistent high disease activity despite conventional disease-modifying anti-rheumatic drugs (cDMARDs) or patients with contraindications to cDMARDs or poor prognostic factors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b50509a1cb95c31db7350bc7993f0a6f
https://strathprints.strath.ac.uk/74286/1/Al_Herz_etal_CR_2020_Accessibility_to_biologics_and_its_impact_on_disease_activity.pdf
https://strathprints.strath.ac.uk/74286/1/Al_Herz_etal_CR_2020_Accessibility_to_biologics_and_its_impact_on_disease_activity.pdf
Autor:
Namas R; Department of Internal Medicine, Division of Rheumatology, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Elarabi M; Department of Internal Medicine, Division of Rheumatology, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Fayad F; Rheumatology Department, Hotel-Dieu de France Hospital, Lebanon and Saint Joseph University of Beirut-Beirut (Lebanon), Beirut, Lebanon., Muhanna Ghanem AA; Rheumatology Unit, Mubarak Al Kabeer Hospital, Jabriya, Kuwait., Al-Herz A; Department of Rheumatology, Amiri Hospital, Kuwait City, Kuwait., Hafiz W; Department of Medicine, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia., Joshi A; Department of Rheumatology, Burjeel Day Surgery, Abu Dhabi, United Arab Emirates., Merashli M; Division of Rheumatology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon., Okais J; Rheumatology Department, Hotel-Dieu de France Hospital, Lebanon and Saint Joseph University of Beirut-Beirut (Lebanon), Beirut, Lebanon., Uthman I; Division of Rheumatology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon., Essa KS; Rheumatology Unit, Farwaniya Hospital, Kuwait City, Kuwait., Omair MA; Department of Medicine, King Saud University, Riyadh, Saudi.
Publikováno v:
Open access rheumatology : research and reviews [Open Access Rheumatol] 2023 May 29; Vol. 15, pp. 93-102. Date of Electronic Publication: 2023 May 29 (Print Publication: 2023).